Dexlansoprazole 60 MG

DRUG3 trials

Sponsors

HK inno.N Corporation, American University of Beirut Medical Center, Ayman Magd Eldin Mohammad Sadek

Conditions

GERDGastroesophageal Reflux DiseaseHealthyProton Pump InhibitorVonoprazan

Phase 1

Pharmacodynamic Properties of CJ-12420 on Evening Dosing

CompletedNCT03043521

HK inno.N CorporationHealthy

Start: 2015-05-13End: 2015-08-12Updated: 2017-02-06

Phase 4

An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan

CompletedNCT03079050

American University of Beirut Medical CenterGERD, Proton Pump Inhibitor

Start: 2017-02-27End: 2017-07-30Updated: 2017-09-15

Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux Disease

CompletedNCT06778395

Ayman Magd Eldin Mohammad SadekGastroesophageal Reflux Disease, Proton Pump Inhibitor, Vonoprazan

Start: 2024-10-01End: 2024-12-31Updated: 2025-02-27

Related Papers

Dexlansoprazole is Effective in Relieving Heartburn during the Fasting Month of Ramadan

Digestive Diseases2019-01-013 citations